EVH

Evolent Health, Inc Class A Common Stock

4.58

USD

+0.04

+0.88%

Nov 06, 15:59 UTC -5

Closed

After-Market

4.56

-0.02

-0.52%

Evolent Health, Inc Class A Common Stock (EVH) Earnings

EVH Earnings Reports

Positive Surprise Ratio

EVH beat 34 of 44 last estimates.

77%

Next Report

Date of Next Report

Feb 22, 2027

Estimate for Q4 26 (Revenue/ EPS)

$764.17M

$0.13

Implied change from Q3 26 (Revenue/ EPS)

+5.35%

+116.67%

Implied change from Q4 25 (Revenue/ EPS)

+63.03%

+62.50%

Evolent Health, Inc Class A Common Stock earnings per share and revenue

On Nov 05, 2026, EVH reported earnings of 0.06 USD per share (EPS) for Q3 26, beating the estimate of 0.05 USD, resulting in a 13.21% surprise. Revenue reached 725.37 million, compared to an expected 731.43 million, with a -0.83% difference. The market reacted with a -5.42% price change (close before vs. close after earnings).

Looking ahead to Q4 26, -- analysts forecast an EPS of 0.13 USD, with revenue projected to reach 764.17 million USD, implying an increase of 116.67% EPS, and increase of 5.35% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Enovis Corporation

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.78

Actual

$0.88

Surprise

+12.07%

Fulgent Genetics, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.66

Actual

-$0.09

Surprise

+86.43%

Health Catalyst, Inc Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.04

Actual

-$0.03

Surprise

+38.14%

Outset Medical, Inc. Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

-$0.71

Actual

-$0.68

Surprise

+4.78%

CareCloud, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.11

Actual

$0.14

Surprise

+19.35%

10x Genomics, Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.26

Actual

-$0.15

Surprise

+43.35%

Doximity, Inc.

Report Date

Nov 05, 2026 For Q2 27

Estimate

$0.35

Actual

$0.36

Surprise

+0.56%

iRhythm Holdings, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.06

Actual

$0.82

Surprise

+1,214.10%

Privia Health Group, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.09

Actual

$0.10

Surprise

+3.73%

Nyxoah SA Ordinary Shares

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.30

Actual

-$0.17

Surprise

+42.29%

FAQ

What were Evolent Health, Inc Class A Common Stock's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Evolent Health, Inc Class A Common Stock reported EPS of $0.06, beating estimates by 13.21%, and revenue of $725.37M, -0.83% below expectations.

How did the market react to Evolent Health, Inc Class A Common Stock's Q3 2026 earnings?

The stock price moved down -5.42%, changed from $4.80 before the earnings release to $4.54 the day after.

When is Evolent Health, Inc Class A Common Stock expected to report next?

The next earning report is scheduled for Feb 22, 2027.

What are the forecasts for Evolent Health, Inc Class A Common Stock's next earnings report?

Based on -- analysts, Evolent Health, Inc Class A Common Stock is expected to report EPS of $0.13 and revenue of $764.17M for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.